SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022

被引：3

作者：

Teran, Richard A. ^{[1
,2
,3
]}

Gagner, Alexandra ^{[2
]}

Gretsch, Stephanie ^{[2
]}

Lauritsen, Jeff ^{[2
]}

Galanto, Daniel ^{[2
]}

Walblay, Kelly ^{[2
]}

Ruestow, Peter ^{[2
]}

Korban, Colin ^{[2
]}

Pacilli, Massimo ^{[2
]}

Kern, David ^{[2
]}

Black, Stephanie R. ^{[2
]}

Tabidze, Irina ^{[2
]}

机构：

[1] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H21-10, Atlanta, GA 30329 USA

[2] Chicago Dept Publ Hlth, Chicago, IL USA

[3] CDCP, 1600 Clifton Rd NE Mailstop H24-4, Atlanta, GA 30329 USA

来源：

EMERGING INFECTIOUS DISEASES | 2023年 / 29卷 / 11期

关键词：

CORONAVIRUS DISEASE 2019; UNITED-STATES; COVID-19; VACCINATION; INFECTION; ADULTS; HOSPITALIZATION; INDIVIDUALS; ILLNESS; RATES;

D O I：

10.3201/eid2911.230577

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance. To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult longitudinally from their first reported infection through May 31, 2022. We matched SARS-CoV-2 laboratory data and COVID-19 vaccine administration data to Chicago's Enhanced HIV/AIDS Reporting System. Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH and 23,642/450,701 (5%) persons without HIV. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57-77] cases/1,000 person-years) than PWOH (50 [95% CI adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27-1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.

引用

页码：2257 / 2265

页数：9

共 50 条

[1] Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022
Galmiche, Simon
Charmet, Tiffany
Rakover, Arthur
Schaeffer, Laura
Cheny, Olivia
von Platen, Cassandre
Omar, Faiza
David, Christophe
Mailles, Alexandra
Carrat, Fabrice
Fontanet, Arnaud
JAMA NETWORK OPEN, 2023, 6 (09) : E2334084
[2] Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020-2022
Sisay, Abay
Tshiabuila, Derek
van Wyk, Stephanie
Tesfaye, Abraham
Mboowa, Gerald
Oyola, Samuel O.
Tesema, Sofonias Kifle
Baxter, Cheryl
Martin, Darren
Lessells, Richard
Tegally, Houriiyah
Moir, Monika
Giandhari, Jennifer
Pillay, Sureshnee
Singh, Lavanya
Ramphal, Yajna
Maharaj, Arisha
Pillay, Yusasha
Maharaj, Akhil
Naidoo, Yeshnee
Ramphal, Upasana
Chabuka, Lucious
Wilkinson, Eduan
de Oliveira, Tulio
Desta, Adey Feleke
San, James E.
GENES, 2023, 14 (03)
[3] Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022
Solastie, Anna
Nieminen, Tuomo
Ekstrom, Nina
Nohynek, Hanna
Lehtonen, Lasse
Palmu, Arto A.
Melin, Merit
EMERGING MICROBES & INFECTIONS, 2023, 12 (02)
[4] An overview of SARS-CoV-2 variants circulating in the 2020-2022 period in Lombardy
Giardina, Federica
Ferrari, Guglielmo
Zavaglio, Federica
Paolucci, Stefania
Rovida, Francesca
Campanini, Giulia
Pellegrinelli, Laura
Galli, Cristina
Pariani, Elena
Bergami, Federica
Nava, Alice
Matarazzo, Elisa
Renica, Silvia
Fanti, Diana
Cento, Valeria
Alteri, Claudia
Scaglione, Francesco
Vismara, Chiara
Perno, Carlo Federico
Piralla, Antonio
Baldanti, Fausto
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 107 (04)
[5] SARS-CoV-2 seroprevalence among people living with HIV in the German HIV-1 Seroconverter Cohort, 2020-2022
Hohn, Oliver
Meixenberger, Karolin
Volkwein, Alexander
Koerner, Kyra
Icli, Suheda
Koppe, Uwe
Hower, Martin
Bremer, Viviane
Gunsenheimer-Bartmeyer, Barbara
Bannert, Norbert
BMC INFECTIOUS DISEASES, 2024, 24 (01)
[6] Evaluation of wastewater surveillance for SARS-CoV-2 in Massachusetts correctional facilities, 2020-2022
Klevens, R. Monina
Young, Cristin C. W.
Olesen, Scott W. W.
Osinski, Anthony
Church, Daniel
Muten, Jennifer
Chou, Lori
Segal, Tami
Cranston, Kevin
FRONTIERS IN WATER, 2023, 5
[7] Molecular detection and characterization of SARS-CoV-2 in wastewater in Thailand during 2020-2022
Kumthip, Kattareeya
Khamrin, Pattara
Yodmeeklin, Arpaporn
Ushijima, Hiroshi
Maneekarn, Niwat
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (11) : 1884 - 1890
[8] Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
Briggs, Jessica
Takahashi, Saki
Nayebare, Patience
Cuu, Gloria
Rek, John
Zedi, Maato
Kizza, Timothy
Arinaitwe, Emmanuel
Nankabirwa, Joaniter I.
Kamya, Moses
Jagannathan, Prasanna
Jacobson, Karen
Rosenthal, Philip J.
Dorsey, Grant
Greenhouse, Bryan
Ssewanyana, Isaac
Rodriguez-Barraquer, Isabel
JAMA NETWORK OPEN, 2023, 6 (02) : E2255978
[9] The Development of the SARS-CoV-2 Epidemic in Different Regions of Siberia in the 2020-2022 Period
Palyanova, Natalia V.
Sobolev, Ivan A.
Palyanov, Andrey Yu.
Kurskaya, Olga G.
Komissarov, Andrey B.
Danilenko, Daria M.
Fadeev, Artem V.
Shestopalov, Alexander M.
VIRUSES-BASEL, 2023, 15 (10):
[10] Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022
Wang, Christina X.
Kohli, Rhea
Olaker, Veronica R.
Terebuh, Pauline
Xu, Rong
Kaelber, David C.
Davis, Pamela B.
MOLECULAR PSYCHIATRY, 2024, 29 (05) : 1350 - 1360

← 1 2 3 4 5 →